Officer sold ~$785K of Vertex Pharmaceuticals
Scheduled in advanceLoading…
Traded May 12, 2026 · Filed May 14, 2026
Vertex Pharmaceuticals's and CMO sold $3.14M of Vertex Pharmaceuticals shares. It was planned long ago, so it says very little.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$3,144,600
Shares × reported transaction price
8 days after results of May 4, 2026, 83 days before results of Aug 3, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $448.29 on May 12, 2026, 22% above its 52-week low and 10% below its high, after a 1% rise over the previous 30 trading days
52-week range $366.54 (Aug 8, 2025) to $499.17 (Mar 10, 2026), 62% of the way up, from 251 adjusted closes. 30 trading days earlier: $443.16 on Mar 30, 2026. Describes the past only, not a forecast
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | -0.6% | +0.9% | -1.4% |
| 30 days | +3.1% | +2.1% | +1.0% |
| 90 days | +18.2% | +5.2% | +12.9% |
Past results only. Not a forecast.
Officer sold ~$785K of Vertex Pharmaceuticals
Scheduled in advanceOfficer sold ~$364K of Vertex Pharmaceuticals
Scheduled in advanceOfficer sold ~$888K of Vertex Pharmaceuticals
Scheduled in advance